Table 1. HLA typing and levels of HLA-DP... | American Society of Hematology

Table 1.

HLA typing and levels of HLA-DP surface expression of patient, donor, and allogeneic BLCLs used as targets for cytotoxicity assays in this study

BLCL	A*	B*	Cw*	DRB1*	DQB1*	DPA1*	DPB1*	MFI
Patient	0201, 3001	3901, 4901	0701, 1203	0701, 1601	0202, 0502	0103	0201, 0402	1485
Donor	3001	3901, 4901	0701, 1203	0701, 1601	0202, 0502	0103, 0201	0201, 0901	1159
BM21	0101	4101	1701	1101	0301	0201	1001	1097
HSRSL	03, 32	1402, 3508	0802, 1502	0102, 1601	0501, 0502	ND	0201, 1701	642
OLL	3101	1501, 1520	0102, 0304	0802	0402	0103	0301, 0402	1171
DKM366	0101, 0205	3502, 5001	0401, 0602	0701, 1104	0202, 0301	ND	0401, 1401	670
C212	ND	ND	ND	0101, 1301	0501, 0603	0103, 0201	0401, 4501	777
WT100BIS	1101	3501	0401	0101	0501	0201	0101	ND
BEL8-CC	ND	ND	ND	0101, 0103	0501	0103	0201, 2001	854

BLCL	A*	B*	Cw*	DRB1*	DQB1*	DPA1*	DPB1*	MFI
Patient	0201, 3001	3901, 4901	0701, 1203	0701, 1601	0202, 0502	0103	0201, 0402	1485
Donor	3001	3901, 4901	0701, 1203	0701, 1601	0202, 0502	0103, 0201	0201, 0901	1159
BM21	0101	4101	1701	1101	0301	0201	1001	1097
HSRSL	03, 32	1402, 3508	0802, 1502	0102, 1601	0501, 0502	ND	0201, 1701	642
OLL	3101	1501, 1520	0102, 0304	0802	0402	0103	0301, 0402	1171
DKM366	0101, 0205	3502, 5001	0401, 0602	0701, 1104	0202, 0301	ND	0401, 1401	670
C212	ND	ND	ND	0101, 1301	0501, 0603	0103, 0201	0401, 4501	777
WT100BIS	1101	3501	0401	0101	0501	0201	0101	ND
BEL8-CC	ND	ND	ND	0101, 0103	0501	0103	0201, 2001	854

MFI indicates mean fluorescence intensity of BLCLs after cell surface staining with the HLA-DP-specific mAb B7/21; ND, not determined.